Erectile Dysfunction Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019
Erectile Dysfunction Drugs Market (Viagra, Cialis, Levitra/Staxyn, Stendra/Spedra, Zydena, MUSE, Mvix and Helleva) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019
Erectile Dysfunction Drugs Market (Viagra, Cialis, Levitra/Staxyn, Stendra/Spedra, Zydena, MUSE, Mvix and Helleva) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Erectile</strong> <strong>Dysfunction</strong> <strong>Drugs</strong> <strong>Market</strong><br />
REPORT DESCRIPTION<br />
<strong>Erectile</strong> <strong>Dysfunction</strong> <strong>Drugs</strong> <strong>Market</strong> - <strong>Global</strong> <strong>Industry</strong> <strong>Analysis</strong>, <strong>Size</strong>, <strong>Share</strong>,<br />
<strong>Growth</strong>, <strong>Trends</strong> <strong>and</strong> <strong>Forecast</strong>, <strong>2013</strong> <strong>–</strong> <strong>2019</strong><br />
In a new report titled ‘<strong>Erectile</strong> <strong>Dysfunction</strong> <strong>Drugs</strong> <strong>Market</strong> - <strong>Global</strong> <strong>Industry</strong> <strong>Analysis</strong>, <strong>Size</strong>, <strong>Share</strong>,<br />
<strong>Growth</strong>, <strong>Trends</strong> <strong>and</strong> <strong>Forecast</strong>, <strong>2013</strong> - <strong>2019</strong>,’ published by Transparency <strong>Market</strong> Research, research<br />
analysts state that the global erectile dysfunction drugs market is expected to decline at a CAGR<br />
of 4.5% in the forecast period <strong>2013</strong> to <strong>2019</strong>. This market was valued at US$4.3 billion in 2012 but<br />
is, however, expected to reach an estimated value of US$3.4 billion in <strong>2019</strong>.<br />
<strong>Erectile</strong> dysfunction is a very common medical disorder in men. It typically affects men older<br />
than 40 years in age <strong>and</strong> can be postulated as an age-related condition too. But at some point in<br />
time, men may also face erectile dysfunction due to psychological <strong>and</strong> physiological factors.<br />
According to the research led by the analysts at TMR, the global erectile dysfunction drugs<br />
market is mainly driven by a rise in incidences of various diseases, rising geriatric population,<br />
increasing focus on awareness <strong>and</strong> education, <strong>and</strong> shifting preference towards a sedentary<br />
lifestyle.<br />
Browse the full <strong>Erectile</strong> <strong>Dysfunction</strong> <strong>Drugs</strong> <strong>Market</strong> Report @ :<br />
http://www.transparencymarketresearch.com/erectile-dysfunctiondrugs.html<br />
Moreover, the growing impact of clinical tests <strong>and</strong> trials for erectile dysfunction drugs contributes<br />
vastly to the growth in the erectile dysfunction drugs market. Some other areas that hold plenty<br />
of growth opportunities in this market are innovative drug delivery, blockbuster patent<br />
expirations, new test techniques, <strong>and</strong> molecule combinations.<br />
Three major erectile dysfunction drugs - Cialis (tadalafil), Viagra (sildenafil citrate), <strong>and</strong><br />
Levitra/Staxyn (vardenafil) <strong>–</strong> have been studied in this research report. Some more br<strong>and</strong>ed<br />
Transparency <strong>Market</strong> Research<br />
2
Change language